OB/GYN 1502 - OB/GYN Clinical Alert - Feb 01, 2011

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Jeffrey T. Jensen, MD, MPH
Leon Speroff
Professor and Vice Chair for Research
Department Obstetrics and Gynecology
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Associate Professor
Department of OB/GYN
Oregon Health & Science University
Portland

Associate Editors
Alison Edelman, MD, MPH
Associate Professor
Assistant Director of the Family Planning Fellowship
Department of Obstetrics & Gynecology
Oregon Health & Science University
Portland

John C. Hobbins, MD
Professor
Department of Obstetrics and Gynecology
University of Colorado Health Sciences Center
Denver

Frank W. Ling, MD
Clinical Professor
Department of Obstetrics and Gynecology
Vanderbilt University School of Medicine
Nashville

Robert L. Coleman, MD
Professor, University of Texas
M.D. Anderson Cancer Center
Houston, TX

Subjects:

  • Rivaroxaban: A Fixed-dose Regimen for Anticoagulation
  • The IUD: An Upstream Battle to Clear Its Name
  • Early Delivery: Neonatal Outcomes After Demonstrated Fetal Lung Maturity Before 39 Weeks of Gestation
  • Are Procedural Complications Related to Sleep Pattern the Night Before?
  • Single Umbilical Artery: Need for Specialist Fetal Echocardiography
  • Complications of Products Developed to Prevent Complications

Objectives:

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women?s health

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Jeffrey T. Jensen, MD, MPH, receives research support from, is a consultant to, and serves on the speakers bureau of Bayer Healthcare/Bayer Schering; he also receives research support from Wyeth and Warner-Chilcott and is a consultant to Schering Plough. Peer Reviewer Catherine LeClair, MD, Associate Editors Alison Edelman, MD, MPH, John C. Hobbins, MD, Frank W. Ling, MD, and Robert L. Coleman, MD, report no financial relationship to this field of study.

Copyright 2011 AHC Media. All rights reserved.